Performance Contribution

Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Woodford Patient Capital Trust plc

Home > Funds > Woodford Patient Capital Trust plc > Performance Contribution

We recognise that openness and transparency are key in building client understanding and we ensure that our clients get unprecedented levels of clear and relevant information about their investments, including unparalleled access to our Investment team and transparency into our portfolio construction and performance contribution.

To keep our investors informed, we are committed to providing full disclosure of the performance contribution of the Woodford Patient Capital Trust’s holdings on a quarterly basis.

Please find the performance contribution of the portfolio holdings below.

The details set out are for information purposes only. Care is taken in ensuring this is accurate as at the stated date. However, this is not guaranteed and the portfolio may change at any time and listed holdings may no longer be represented in the trust. This does not constitute investment advice or any recommendation with regard to the listed stocks.

Performance contribution

Source: Financial Express, Woodford, as at 31 December 2017

Full portfolio contribution

1 year to 31 December 2017
Stock Sector Country Stock return (%) Average weight (%) Contribution (%)
Purplebricks Financials United Kingdom 194.73 8.22 6.57
Immunocore Health Care United Kingdom 19.86 6.53 1.02
Horizon Discovery Health Care United Kingdom -- 1.35 0.97
Ultrahaptics Technology United Kingdom -- 1.79 0.92
Oxford Nanopore Health Care United Kingdom 10.00 8.52 0.79
Mereo Biopharma Health Care United Kingdom 21.53 4.13 0.77
Gigaclear Telecommunications United Kingdom 33.20 2.41 0.62
Silence Therapeutics Health Care United Kingdom -- 0.53 0.49
A J Bell Financials United Kingdom 32.10 1.25 0.35
Kind Consumer Consumer Goods United Kingdom -- 0.70 0.28
Atom Bank Financials United Kingdom 15.00 2.82 0.27
Eve Sleep Consumer Goods United Kingdom -- 0.54 0.22
Cequr Health Care Switzerland 19.08 1.00 0.20
Seedrs Pref Financials United Kingdom -- 0.82 0.19
Xeros Industrials United Kingdom 19.85 1.17 0.18
PsiOxus Health Care United Kingdom 72.50 0.34 0.16
Abzena Health Care United Kingdom -- 0.37 0.10
Kymab Health Care United Kingdom -- 2.57 0.09
Netscientific Health Care United Kingdom 8.40 0.76 0.09
AMO Pharma Health Care United Kingdom 0.48 0.96 0.01
Nexeon Industrials United Kingdom 0.00 0.65 0.00
Mission Therapeutics Health Care United Kingdom 0.00 0.80 0.00
Ratesetter Financials United Kingdom -- 0.31 0.00
Inivata Health Care United Kingdom 0.00 1.01 0.00
Cell Medica Health Care United Kingdom -- 1.02 0.00
Proton Partners International Health Care United Kingdom 0.00 4.23 0.00
Oxford Sciences Innovation Financials United Kingdom 0.00 3.39 0.00
Benevolent AI Technology United Kingdom 0.00 2.55 0.00
Accelerated Digital Ventures Financials United Kingdom 0.31 0.00
Cambridge Innovation Capital Financials United Kingdom 0.00 0.25 0.00
Genomics Health Care United Kingdom -- 0.03 0.00
Bodle Technologies Technology United Kingdom -- 0.01 0.00
Metaboards Technology United Kingdom -- 0.01 0.00
Yoyo Wallet Technology United Kingdom -- 0.06 0.00
Sabina Estates Pref C Financials United Kingdom -- 0.14 0.00
Econic Industrials United Kingdom 0.00 0.20 0.00
Dementia Discovery Fund Health Care United Kingdom -- 0.15 0.00
Fibre 7 Industrials United Kingdom -- 0.27 0.00
Abaco Capital Health Care United Kingdom -- 0.30 -0.01
ABLS Capital Health Care United Kingdom -- 0.06 -0.01
Arix Bioscience Financials United Kingdom -- 1.97 -0.02
Halosource Industrials United Kingdom -68.24 0.08 -0.02
American Financial Exchange Financials United States -8.66 0.19 -0.02
Carrick Therapeutics Health Care United Kingdom -- 0.07 -0.02
Midatech Pharma Health Care United Kingdom -- 0.01 -0.02
Draper Esprit Financials United Kingdom -- 0.65 -0.05
Mafic Industrials Luxembourg -- 0.66 -0.06
Tissue Regenix Health Care United Kingdom -- 0.12 -0.07
Circassia Health Care United Kingdom -- 0.84 -0.08
Northwest Biotherapeutics Health Care United States -38.28 0.14 -0.08
SciFluor Life Sciences Health Care United States -8.66 1.08 -0.10
Precision Biopsy Health Care United States -8.66 1.05 -0.10
Itaconix Basic Materials United Kingdom -- 0.27 -0.10
Novabiotics Health Care United Kingdom -- 0.25 -0.11
Federated Wireless Technology United States -- 0.72 -0.13
Origin Health Care United States -- 0.16 -0.17
Verseon Health Care United Kingdom -- 1.01 -0.17
Touchstone Innovations Financials United Kingdom -- 1.30 -0.20
Hvivo Health Care United Kingdom -- 0.19 -0.20
Mercia Technologies Financials United Kingdom -28.21 0.70 -0.25
Sphere Medical Warrant Health Care United Kingdom -- 0.26 -0.29
Evofem Health Care United States -- 0.62 -0.31
Autolus Health Care United Kingdom -- 2.28 -0.32
Utilitywise Industrials United Kingdom -- 0.30 -0.32
Metalysis Industrials United Kingdom -44.98 0.66 -0.33
Benchmark Health Care United Kingdom -31.81 1.04 -0.37
ReNeuron Health Care United Kingdom -28.57 1.22 -0.44
Thin Film Electronics Industrials Norway -- 1.05 -0.48
IP Group Financials United Kingdom -- 0.94 -0.50
Drayson Technologies C Technology United Kingdom -- 1.14 -0.51
Ombu Financials United Kingdom -- 1.85 -0.55
Malin Financials Ireland -27.28 1.94 -0.57
Industrial Heat Industrials United Kingdom -- 1.47 -0.67
Idex Technology Norway -29.03 2.31 -0.68
Theravance Biopharma Health Care United States -20.00 4.83 -0.72
Vernalis Health Care United Kingdom -74.36 0.95 -1.20
RM2 International Industrials United Kingdom -- 0.60 -1.39
4D Pharma Health Care United Kingdom -52.36 1.71 -1.59
Allied Minds Financials United Kingdom -70.91 1.66 -2.60
Prothena Health Care United States -30.11 14.72 -4.28

Source: Northern Trust

Performance contributions are calculated on a total return basis, including the impact of intra-period trading, gross of fees in sterling using closing prices. Contribution totals may therefore not match fund performance data from other data sources which may be based on midday prices, net of fees. Values do not always sum due to rounding. Stock returns can only be calculated where the position has been held by the fund for the full period. Individual securities which relate to the same holding have been aggregated together where appropriate.

Past performance is not a guide to future returns. This data is provided for information purposes only and should not be reproduced, published or disseminated in any manner. Care is taken in ensuring this is accurate as at the stated date. However, this is not guaranteed, and the portfolio may change at any time. This does not constitute investment advice or any recommendation with regard to the listed stocks.

What are the risks?

  • Young businesses have a different risk profile to mature blue-chip companies – risks are much more stock-specific, which implies a lower correlation with equity markets and the wider economy
  • Long-term outcomes are more binary – extremely attractive rewards for success but some businesses will inevitably fail to fulfil their potential and this may expose investors to the risk of capital losses
  • As it can take years for young businesses to fulfil their potential, this investment requires patience
  • The value of the trust as well as any income it pays will fluctuate which may partly be the result of exchange rate changes
  • The price of shares in the trust is determined by market supply and demand, and this may be different to the net asset value of the trust
  • The trust may invest in overseas securities and be exposed to currencies other than pound sterling
  • The trust may invest in unquoted securities, which may be less liquid and more difficult to realise than publicly traded securities

Important information

We do not give investment advice so you need to decide if an investment is suitable for you. If you are unsure whether to invest, you should contact a financial adviser. The trust currently intends to conduct its affairs so that its securities can be recommended by IFAs to ordinary retail investors in accordance with the FCA’s rules in relation to non-mainstream investment products and intends to continue to do so for the foreseeable future. The securities are excluded from the FCA’s restrictions which apply to non-mainstream investment products because they are shares in an investment trust.

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address Beaufort House, 51 New North Road, Exeter, EX4 4EP.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland. The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at www.fundinfo.com.

© 2018 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement